By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Astellas Pharma Inc. 

3-11 Nihonbashi-Honcho 2-chome

Chuo-ku  Tokyo  103-8411  Japan
Phone: 81-3-3244-3000 Fax: 81-3-3244-3272





Gilead (Durham, NC) 

Company News
Jennifer Saputo Joins Astellas Pharma Inc. (ALPMY) Corporate Affairs 4/15/2015 10:39:00 AM
Ventana Medical Systems, Inc. (VMSI) And Astellas Pharma Inc. (ALPMY) Join Forces To Leverage Novel Companion Diagnostic Tests For Targeted Cancer Treatments 4/14/2015 9:16:33 AM
Astellas Pharma Inc. (ALPMY) Appoints Shontelle Dodson To Lead Medical Excellence Function 4/6/2015 10:17:24 AM
MD Anderson Cancer Center, Astellas Pharma Inc. (ALPMY) Sign Option Agreement For Monoclonal Antibody Drug Targeting Acute Myeloid Leukemia 4/3/2015 7:13:13 AM
Astellas Pharma Inc. (ALPMY) Release: Enzalutamide Demonstrates Statistically Significant Improvement In Progression Free Survival Compared With Bicalutamide In Strive Trial 4/2/2015 6:56:36 AM
Vical Incorporated (VICL) Expands Infectious Disease Portfolio With Novel Antifungal From Astellas Pharma Inc. (ALPMY) 3/26/2015 11:09:54 AM
Astellas Pharma Inc. (ALPMY) And Medivation, Inc. (MDVN) Announce New Enzalutamide Data Presented During Plenary Presentations At The 2015 European Association Of Urology Congress 3/24/2015 9:42:26 AM
Astellas Pharma Inc. (ALPMY) Receives FDA Approval for CRESEMBA (isavuconazonium sulfate) For The Treatment Of Invasive Aspergillosis And Invasive Mucormycosis 3/9/2015 6:55:23 AM
Astellas Pharma Inc. (ALPMY) Broadens Regional Leadership And Creates New Corporate Affairs And Corporate Development Functions 2/20/2015 8:39:37 AM
Astellas Pharma Inc. (ALPMY) Launches The Newest Element In Its Global Corporate Brand Campaign On CNN's Global Broadcast Network 2/16/2015 11:39:06 AM